August 28, 2019
According to findings from a study published in Cancer on the utilization of specific supportive care measures in older patients with multiple myeloma, only approximately two-thirds of patients received guideline-concordant administration of a bone-modifying agent. The course of treatment for patients with multiple myeloma is typically characterized by the administration of multiple lines of therapy associated with periods...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand